Dr James V. Watson, MA., MB., BS., M.Sc., DMRT., FFR., FRCR.

MedInfomatics LTD

Dr. Watson is a Clinical Oncologist, initially in Radiotherapy, then Radiation Biology with extensive experience in Medical Oncology and Brachytherapy. Considerable computing experience started with programming as a medical student in 1962. Appointments include Middlesex Hospital and London University, then a move to Cambridge, UK, in 1975 as a Senior Clinical Scientist in the Medical Research Council Centre (MRC, including the Laboratory of Molecular Biology) and University of Cambridge, with consultant oncologist contracts in Addenbrooke''s and Bedford Hospitals. Internationally recognized for his work in cytometry and its application in cancer, he designed a dual-laser flow cytometer with 9 detectors at the MRC in the late 1970s/80s. He was a past President of the International Society for Analytical Cytology (ISAC). James has published extensively with over 250 peer reviewed clinical and scientific papers, over 100 abstracts in subjects as diverse as optics, statistics, computing, clinical medicine, pathology, biochemistry and cytometry.

dont miss

Artificial Intelligence – what it is and usage in Medical Records

Artificial Intelligence can have many meanings. The human brain has key milestone functions including instinct, Imitation, Empathy and Imagination. Within the first years of life, key abilities of the brain are developed to enable survival and development of intelligence. The ability of a computer to emulate such key life processes in the same time scale especially emulating the thought and decision processes of a clinician remain a big challenge.

EVEN MORE SEMINARS

  • Dr Paul Fenton: Speaking at the Oncology Convention

    Dr Paul Fenton
    University Hospital Southampton NHS Foundation Trust

    Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic

  • Prantik Das: Speaking at the Oncology Convention

    Prantik Das
    University Hospital of Derby and Burton NHS Foundation Trust

    The Changing Landscape of Prostate Radiotherapy

  • Dr Penny Kechagioglou: Speaking at the Oncology Convention

    Dr Penny Kechagioglou
    GenesisCare UK

    Breast cancer Service of the Future: a service transformation

  • Dr. Konstantinos Vougas: Speaking at the Oncology Convention

    Dr. Konstantinos Vougas
    DeepMed IO Ltd

    AI in decision support of diagnostic and personalised medicine applications.

  • Dr. Henrik Harling: Speaking at the Oncology Convention

    Dr. Henrik Harling
    2cureX

    IndiTreat® functional profiling, to match effective cancer drug treatment to individual cancer patients